Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.
((Radiology OR Imaging OR CT) AND ("Novel Coronavirus" OR COVID-19 OR SARS-CoV-2 OR 2019-nCoV))
11,168 results
  • Capturing Cytokines with Advanced Materials: A Potential Strategy to Tackle COVID-19 Cytokine Storm. [Journal Article]
    Adv Mater. 2021 Apr 10 [Online ahead of print]Meng QF, Tian R, … Rao L
  • The COVID-19 pandemic, induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused great impact on the global economy and people's daily life. In the clinic, most patients with COVID-19 show none or mild symptoms, while approximately 20% of them develop severe pneumonia, multiple organ failure, or septic shock due to infection-induced cytokine release syndrome (the so-call…
  • Get Protected! Recommendations for Staff in IR. [Review]
    Cardiovasc Intervent Radiol. 2021 Apr 09 [Online ahead of print]Bartal G, Vano E, Paulo G
  • CONCLUSIONS: The review is completed with a summary of the main factors to be considered in the selection of the appropriate radiation protection tools and practical advices to improve the protection of the staff.
  • Depression and anxiety in pregnancy during COVID-19: A rapid review and meta-analysis. [Journal Article]
    Psychiatry Res. 2021 Apr 01; 300:113912.Tomfohr-Madsen LM, Racine N, … Madigan S
  • The study rapidly reviewed and meta-analyzed the worldwide prevalence of depression and anxiety among pregnant women during the COVID-19 pandemic. A systematic search of the literature and meta-analyses were conducted from December 2019 - February 2021 with a total of 46 studies meeting inclusion criteria. Depression was assessed in 37 studies (N = 47,677), with a pooled prevalence of 25.6%. Anxi…
  • Focused Role of Nanoparticles Against COVID-19: Diagnosis and Treatment. [Review]
    Photodiagnosis Photodyn Ther. 2021 Apr 06 [Online ahead of print]Dheyab MA, Khaniabadi PM, … Khaleel HA
  • The 2019 novel coronavirus (2019-nCoV; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)) has witnessed a rapid and global proliferation since its early identification in patients with severe pneumonia in Wuhan, China. As of 27th May 2020, 2019-nCoV cases have risen to >5 million, with confirmed deaths of 350,000. However, Coronavirus disease (COVID-19) diagnostic and treatment measure…
  • TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation. [Journal Article]
    Cell. 2021 Mar 30 [Online ahead of print]Ho JSY, Mok BW, … Marazzi I
  • The ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently affecting millions of lives worldwide. Large retrospective studies indicate that an elevated level of inflammatory cytokines and pro-inflammatory factors are associated with both increased disease severity and mortality. Here, using multidimensional epigenetic, transcriptional, in vitro, and i…
  • Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. [Journal Article]
    N Engl J Med. 2021 Apr 09 [Online ahead of print]Schultz NH, Sørvoll IH, … Holme PA
  • We report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving the first dose of the ChAdOx1 nCoV-19 adenoviral vector vaccine against coronavirus disease 2019 (Covid-19). The patients were health care workers who were 32 to 54 years of age. All the patients had high levels of antibodies to platelet factor 4-polyanion complexes; however,…
  • Acute pulmonary embolism in patients presenting pulmonary deterioration after hospitalization for non-critical COVID-19. [Journal Article]
    Intern Med J. 2021 Apr 08 [Online ahead of print]Polo Friz H, Gelfi E, … Boracchi P
  • CONCLUSIONS: Among patients presenting pulmonary deterioration after hospitalization for non-critical COVID-19, the prevalence of APE is high. Traditional diagnostic tools to identify high APE pre-test probability patients do not seem to be clinically useful. These results support the use of a high index of suspicion for performing CTPA to exclude or confirm APE as the most appropriate diagnostic approach in this clinical setting. This article is protected by copyright. All rights reserved.
New Search Next